An open label, randomized, phase II study of AS1404 in combination with carboplatin and paclitaxel in patients with platinum-sensitive recurrent ovarian epithelial cancer

Trial Profile

An open label, randomized, phase II study of AS1404 in combination with carboplatin and paclitaxel in patients with platinum-sensitive recurrent ovarian epithelial cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Carboplatin; Paclitaxel; Vadimezan
  • Indications Ovarian cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Sep 2007 Interim results presented at ECCO 2007.
    • 11 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top